Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Escherichia Coli | Research

Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential

Authors: Tamirat Salile Sada, Tesfaye Sisay Tessema

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Escherichia coli is a common fecal coliform, facultative aerobic, gram-negative bacterium. Pathogenic strains of such microbes have evolved to cause diarrhea, urinary tract infections, and septicemias. The emergence of antibiotic resistance urged the identification of an alternative strategy. The use of lytic bacteriophages against the control of pathogenic E. coli in clinics and different environmental setups (waste and drink water management) has become an alternative therapy to antibiotic therapy. Thus, this study aimed to isolate and characterize lytic bacteriophage from various sources in Addis Ababa, tested them against antimicrobial-resistant diarrheagenic E. coli strains and evaluated their therapeutic potential under in vitro conditions.

Methods

A total of 14 samples were processed against six different diarrheagenic E. coli strains. The conventional culture and plaque analysis agar overlay method was used to recover lytic bacteriophage isolates. The phage isolates were characterized to determine their lytic effect, growth characteristics, host range activity, and stability under different temperature and pH conditions. Phage isolates were identified by scanning electron microscope (SEM), and molecular techniques (PCR).

Results

In total, 17 phages were recovered from 84 tested plates. Of the 17 phage isolates, 11 (65%) were Myoviridae-like phages, and 6 (35%) phage isolates were Podoviridae and Siphoviridae by morphology and PCR identification. Based on the host range test, growth characteristics, and stability test 7 potent phages were selected. These phages demonstrated better growth characteristics, including short latent periods, highest burst sizes, and wider host ranges, as well as thermal stability and the ability to survive in a wide range of pH levels.

Conclusions

The promising effect of the phages isolated in this study against AMR pathogenic E. coli has raised the possibility of their use in the future treatment of E. coli infections.
Appendix
Available only for authorised users
Literature
1.
go back to reference Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic E. coli. Clin Microbiol Rev. 2013;26(4):822–80.PubMedPubMedCentralCrossRef Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic E. coli. Clin Microbiol Rev. 2013;26(4):822–80.PubMedPubMedCentralCrossRef
2.
go back to reference Cabal A, García-Castillo M, Cantón R, Gortázar C, Domínguez L, Álvarez J. Prevalence of E. Coli virulence genes in patients with diarrhea and a subpopulation of healthy volunteers in Madrid, Spain. Front Microbiol. 2016;7:641.PubMedPubMedCentralCrossRef Cabal A, García-Castillo M, Cantón R, Gortázar C, Domínguez L, Álvarez J. Prevalence of E. Coli virulence genes in patients with diarrhea and a subpopulation of healthy volunteers in Madrid, Spain. Front Microbiol. 2016;7:641.PubMedPubMedCentralCrossRef
3.
go back to reference Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive E. Coli interaction in Crohn’s disease: opening up new therapeutic strategies. BioMed Res Int. 2014;2014. Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive E. Coli interaction in Crohn’s disease: opening up new therapeutic strategies. BioMed Res Int. 2014;2014.
4.
go back to reference Conte MP, Longhi C, Marazzato M, Conte AL, Aleandri M, Lepanto MS, Schippa S. Adherent-invasive E. Coli (AIEC) in pediatric Crohn’s disease patients: phenotypic and genetic pathogenic features. BMC Res Notes. 2014;7:1–12.CrossRef Conte MP, Longhi C, Marazzato M, Conte AL, Aleandri M, Lepanto MS, Schippa S. Adherent-invasive E. Coli (AIEC) in pediatric Crohn’s disease patients: phenotypic and genetic pathogenic features. BMC Res Notes. 2014;7:1–12.CrossRef
5.
go back to reference Mora A, Herrrera A, López C, Dahbi G, Mamani R, Pita JM, et al. Characteristics of the Shiga-toxin-producing enteroaggregative E. Coli O104: H4 German outbreak strain and of STEC strains isolated in Spain. Int Microbiol. 2011;14(3):121–41.PubMed Mora A, Herrrera A, López C, Dahbi G, Mamani R, Pita JM, et al. Characteristics of the Shiga-toxin-producing enteroaggregative E. Coli O104: H4 German outbreak strain and of STEC strains isolated in Spain. Int Microbiol. 2011;14(3):121–41.PubMed
7.
go back to reference Akhwale JK, Rohde M, Rohde C, Bunk B, Spröer C, Boga HI, Wittmann J. Isolation, characterization and analysis of bacteriophages from the haloalkaline lake Elmenteita, Kenya. PloS one. 2019;14(4):e0215734.PubMedPubMedCentralCrossRef Akhwale JK, Rohde M, Rohde C, Bunk B, Spröer C, Boga HI, Wittmann J. Isolation, characterization and analysis of bacteriophages from the haloalkaline lake Elmenteita, Kenya. PloS one. 2019;14(4):e0215734.PubMedPubMedCentralCrossRef
8.
go back to reference Bhetwal A, Maharjan A, Shakya S, Satyal D, Ghimire S, Khanal PR, et al. Isolation of potential phages against multidrug-resistant bacterial isolates: promising agents in the rivers of Kathmandu, Nepal. BioMed Res Int. 2017;2017. Bhetwal A, Maharjan A, Shakya S, Satyal D, Ghimire S, Khanal PR, et al. Isolation of potential phages against multidrug-resistant bacterial isolates: promising agents in the rivers of Kathmandu, Nepal. BioMed Res Int. 2017;2017.
9.
go back to reference Ahn and D. Biswas. Influence of bacteriophage P22 on the inflammatory mediator gene expression in chicken macrophage HD11 cells infected with Salmonella Typhimurium. FEMS Microbiol Lett. 2014;352(1):11–7.CrossRef Ahn and D. Biswas. Influence of bacteriophage P22 on the inflammatory mediator gene expression in chicken macrophage HD11 cells infected with Salmonella Typhimurium. FEMS Microbiol Lett. 2014;352(1):11–7.CrossRef
10.
go back to reference Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010;28(12):591–5.PubMedCrossRef Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010;28(12):591–5.PubMedCrossRef
11.
go back to reference Haque M, McKimm J, Sartelli M, Dhingra S, Labricciosa FM, Islam S, Charan J. Strategies to prevent healthcare-associated infections: a narrative overview. Risk Manag Healthc Policy. 2020;13:1765–80.PubMedPubMedCentralCrossRef Haque M, McKimm J, Sartelli M, Dhingra S, Labricciosa FM, Islam S, Charan J. Strategies to prevent healthcare-associated infections: a narrative overview. Risk Manag Healthc Policy. 2020;13:1765–80.PubMedPubMedCentralCrossRef
12.
go back to reference Amarillas L, Rubí-Rangel L, Chaidez C, González-Robles A, Lightbourn-Rojas L, León-Félix J. Isolation and characterization of phiLLS, a novel phage with potential biocontrol agent against multidrug-resistant E. Coli. Front Microbiol. 2017;8:1355.PubMedPubMedCentralCrossRef Amarillas L, Rubí-Rangel L, Chaidez C, González-Robles A, Lightbourn-Rojas L, León-Félix J. Isolation and characterization of phiLLS, a novel phage with potential biocontrol agent against multidrug-resistant E. Coli. Front Microbiol. 2017;8:1355.PubMedPubMedCentralCrossRef
13.
go back to reference d’Hérelle F. Sur un microbe invisible antagoniste des bacilles dysentériques. C R Acad Sci Ser D. 1917;165:373–5. d’Hérelle F. Sur un microbe invisible antagoniste des bacilles dysentériques. C R Acad Sci Ser D. 1917;165:373–5.
14.
go back to reference Twort FW. An investigation on the nature of ultramicroscopic viruses. Lancet. 1915;186:1241–3.CrossRef Twort FW. An investigation on the nature of ultramicroscopic viruses. Lancet. 1915;186:1241–3.CrossRef
15.
go back to reference Hambly E, Suttle CA. The viriosphere, diversity, and genetic exchange within phage communities. Curr Opin Microbiol. 2005;8(4):444–50.PubMedCrossRef Hambly E, Suttle CA. The viriosphere, diversity, and genetic exchange within phage communities. Curr Opin Microbiol. 2005;8(4):444–50.PubMedCrossRef
16.
go back to reference Khan Mirzaei M, Nilsson AS. Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS One. 2015;10:e0118557.PubMedPubMedCentralCrossRef Khan Mirzaei M, Nilsson AS. Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS One. 2015;10:e0118557.PubMedPubMedCentralCrossRef
17.
go back to reference Niu YD, McAllister TA, Nash JH, Kropinski AM, Stanford K. Four E. Coli O157: H7 phages: a new bacteriophage genus and taxonomic classification of T1-like phages. PLoS One. 2014;9(6):e100426.ADSPubMedPubMedCentralCrossRef Niu YD, McAllister TA, Nash JH, Kropinski AM, Stanford K. Four E. Coli O157: H7 phages: a new bacteriophage genus and taxonomic classification of T1-like phages. PLoS One. 2014;9(6):e100426.ADSPubMedPubMedCentralCrossRef
18.
go back to reference Tomat D, Mercanti D, Balagué C, Quiberoni A. Phage biocontrol of enteropathogenic and Shiga toxin-producing E. Coli during milk fermentation. Lett Appl Microbiol. 2013;57(1):3–10.PubMedCrossRef Tomat D, Mercanti D, Balagué C, Quiberoni A. Phage biocontrol of enteropathogenic and Shiga toxin-producing E. Coli during milk fermentation. Lett Appl Microbiol. 2013;57(1):3–10.PubMedCrossRef
19.
go back to reference Liu D, Van Belleghem JD, de Vries CR, Burgener E, Chen Q, Manasherob R, et al. The safety and toxicity of phage therapy: a review of animal and clinical studies. Viruses. 2021;13(7):1268.PubMedPubMedCentralCrossRef Liu D, Van Belleghem JD, de Vries CR, Burgener E, Chen Q, Manasherob R, et al. The safety and toxicity of phage therapy: a review of animal and clinical studies. Viruses. 2021;13(7):1268.PubMedPubMedCentralCrossRef
20.
go back to reference Podlacha M, Grabowski Ł, Kosznik-Kawśnicka K, Zdrojewska K, Stasiłojć M, Węgrzyn G, Węgrzyn A. Interactions of bacteriophages with animal and human organisms—safety issues in the light of phage therapy. Int J Mol Sci. 2021;22(16):8937.PubMedPubMedCentralCrossRef Podlacha M, Grabowski Ł, Kosznik-Kawśnicka K, Zdrojewska K, Stasiłojć M, Węgrzyn G, Węgrzyn A. Interactions of bacteriophages with animal and human organisms—safety issues in the light of phage therapy. Int J Mol Sci. 2021;22(16):8937.PubMedPubMedCentralCrossRef
22.
go back to reference Ateba CN, Akindolire MA. Isolation and characterization of bacteriophages with lytic activity against virulent E. coli O157: H7: Potential biocontrol agents. Preprints.org, Preprints; 2019. p. 2019 2019010132. Ateba CN, Akindolire MA. Isolation and characterization of bacteriophages with lytic activity against virulent E. coli O157: H7: Potential biocontrol agents. Preprints.org, Preprints; 2019. p. 2019 2019010132.
23.
go back to reference Sillankorva S, Pleteneva E, Shaburova O, Santos S, Carvalho C, Azeredo J, Krylov V. Salmonella Enteritidis bacteriophage candidates for phage therapy of poultry. J Appl Microbiol. 2010;108(4):1175–86.PubMedCrossRef Sillankorva S, Pleteneva E, Shaburova O, Santos S, Carvalho C, Azeredo J, Krylov V. Salmonella Enteritidis bacteriophage candidates for phage therapy of poultry. J Appl Microbiol. 2010;108(4):1175–86.PubMedCrossRef
24.
go back to reference Bebeacua C, Tremblay D, Farenc C, Chapot-Chartier MP, Sadovskaya I, Van Heel M, Cambillau C. Structure, adsorption to host, and infection mechanism of virulent lactococcal phage p2. J Virol. 2013;87(22):12302–12.PubMedPubMedCentralCrossRef Bebeacua C, Tremblay D, Farenc C, Chapot-Chartier MP, Sadovskaya I, Van Heel M, Cambillau C. Structure, adsorption to host, and infection mechanism of virulent lactococcal phage p2. J Virol. 2013;87(22):12302–12.PubMedPubMedCentralCrossRef
25.
go back to reference Guttman B, Raya R, Kutter E. Basic phage biology. In: Kutter E, Sulakvelide A, editors. In bacteriophages: biology and applications. Boca Ration: CRC press; 2005. p. 4–28. Guttman B, Raya R, Kutter E. Basic phage biology. In: Kutter E, Sulakvelide A, editors. In bacteriophages: biology and applications. Boca Ration: CRC press; 2005. p. 4–28.
26.
go back to reference Bolocan AS, Callanan J, Forde A, Ross P, Hill C. Phage therapy targeting E. Coli—a story with no end? FEMS Microbiol Lett. 2016;363(22). Bolocan AS, Callanan J, Forde A, Ross P, Hill C. Phage therapy targeting E. Coli—a story with no end? FEMS Microbiol Lett. 2016;363(22).
28.
go back to reference Litt PK, Jaroni D. Isolation and Physiomorphological Characterization of E. coli O157:H7-Infecting Bacteriophages Recovered from Beef Cattle Operations. Int J Microbiol. 2017;7013236. Litt PK, Jaroni D. Isolation and Physiomorphological Characterization of E. coli O157:H7-Infecting Bacteriophages Recovered from Beef Cattle Operations. Int J Microbiol. 2017;7013236.
29.
go back to reference Sjahriani T, Wasito EB, Tyasningsih W. Isolation and identification of Escherichia coli O157: H7 lytic bacteriophage from environment sewage. Int J Food Sci. 2021;2021:1–11.CrossRef Sjahriani T, Wasito EB, Tyasningsih W. Isolation and identification of Escherichia coli O157: H7 lytic bacteriophage from environment sewage. Int J Food Sci. 2021;2021:1–11.CrossRef
30.
go back to reference Zhang H, Yang Z, Zhou Y, Bao H, Wang R, Li T, Zhou X. Application of a phage in decontaminating Vibrio parahaemolyticus in oysters. Int J Food Microbiol. 2018;275:24–31.PubMedCrossRef Zhang H, Yang Z, Zhou Y, Bao H, Wang R, Li T, Zhou X. Application of a phage in decontaminating Vibrio parahaemolyticus in oysters. Int J Food Microbiol. 2018;275:24–31.PubMedCrossRef
31.
go back to reference Akhtar M, Viazis S, Christensen K, Kraemer P, Diez-Gonzalez F. Isolation, characterization and evaluation of virulent bacteriophages against Listeria monocytogenes. Food Control. 2017;75:108–15.CrossRef Akhtar M, Viazis S, Christensen K, Kraemer P, Diez-Gonzalez F. Isolation, characterization and evaluation of virulent bacteriophages against Listeria monocytogenes. Food Control. 2017;75:108–15.CrossRef
32.
go back to reference Smolarska A, Rabalski L, Narajczyk M, Czajkowski R. Isolation and phenotypic and morphological characterization of the first Podoviridae lytic bacteriophages ϕA38 and ϕA41 infecting Pectobacterium parmentieri (former Pectobacterium wasabiae). Eur J Plant Pathol. 2018;150:413–25.CrossRef Smolarska A, Rabalski L, Narajczyk M, Czajkowski R. Isolation and phenotypic and morphological characterization of the first Podoviridae lytic bacteriophages ϕA38 and ϕA41 infecting Pectobacterium parmentieri (former Pectobacterium wasabiae). Eur J Plant Pathol. 2018;150:413–25.CrossRef
33.
go back to reference Vinner GK, Richards K, Leppanen M, Sagona AP, Malik DJ. Microencapsulation of enteric bacteriophages in a pH-responsive solid oral dosage formulation using a scalable membrane emulsification process. Pharmaceutics. 2019;11(9):475.PubMedPubMedCentralCrossRef Vinner GK, Richards K, Leppanen M, Sagona AP, Malik DJ. Microencapsulation of enteric bacteriophages in a pH-responsive solid oral dosage formulation using a scalable membrane emulsification process. Pharmaceutics. 2019;11(9):475.PubMedPubMedCentralCrossRef
34.
go back to reference Dewanggana MN, Evangeline C, Ketty MD, Waturangi DE, Magdalena S. Isolation, characterization, molecular analysis and application of bacteriophage DW-EC to control Enterotoxigenic E. Coli on various foods. Sci Rep. 2022;12(1):1–10.CrossRef Dewanggana MN, Evangeline C, Ketty MD, Waturangi DE, Magdalena S. Isolation, characterization, molecular analysis and application of bacteriophage DW-EC to control Enterotoxigenic E. Coli on various foods. Sci Rep. 2022;12(1):1–10.CrossRef
35.
go back to reference Duc HM, Son HM, Honjoh KI, Miyamoto T. Isolation and application of bacteriophages to reduce Salmonella contamination in raw chicken meat. LWT Food Sci Technol. 2018;91:353–60.CrossRef Duc HM, Son HM, Honjoh KI, Miyamoto T. Isolation and application of bacteriophages to reduce Salmonella contamination in raw chicken meat. LWT Food Sci Technol. 2018;91:353–60.CrossRef
36.
go back to reference Aprea G, D’Angelo AR, Prencipe VA, Migliorati G. Bacteriophage morphological characterization by using transmission electron microscopy. J Life Sci. 2015;9(1):214–20. Aprea G, D’Angelo AR, Prencipe VA, Migliorati G. Bacteriophage morphological characterization by using transmission electron microscopy. J Life Sci. 2015;9(1):214–20.
37.
go back to reference Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8(3):162.PubMedPubMedCentralCrossRef Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8(3):162.PubMedPubMedCentralCrossRef
38.
go back to reference Yang H, Liang LS, Lin, and S. Jia. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 2010;10(1):131.PubMedPubMedCentralCrossRef Yang H, Liang LS, Lin, and S. Jia. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 2010;10(1):131.PubMedPubMedCentralCrossRef
39.
go back to reference Alonso MDC, Rodríguez J, Borrego JJ. Characterization of marine bacteriophages isolated from the Alboran Sea (Western Mediterranean). J Plankton Res. 2002;24(10):1079–87.CrossRef Alonso MDC, Rodríguez J, Borrego JJ. Characterization of marine bacteriophages isolated from the Alboran Sea (Western Mediterranean). J Plankton Res. 2002;24(10):1079–87.CrossRef
41.
go back to reference Leta A, Yohannes M, Kassa T. Assessment of therapeutic potential of bacteriophages to control E. Coli infection in Swiss mice model. Ethiopian J Appl Sci Technol. 2017;8(2):73–83. Leta A, Yohannes M, Kassa T. Assessment of therapeutic potential of bacteriophages to control E. Coli infection in Swiss mice model. Ethiopian J Appl Sci Technol. 2017;8(2):73–83.
43.
go back to reference Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, Adamia R. The phage therapy paradigm: prêt-à-porter or Sur-mesure? Pharm Res. 2011;28:934–7.PubMedCrossRef Pirnay JP, De Vos D, Verbeken G, Merabishvili M, Chanishvili N, Vaneechoutte M, Adamia R. The phage therapy paradigm: prêt-à-porter or Sur-mesure? Pharm Res. 2011;28:934–7.PubMedCrossRef
44.
go back to reference Fischer CR, Yoichi M, Unno H, Tanji Y. The coexistence of E. Coli serotype O157: H7 and its specific bacteriophage in continuous culture. FEMS Microbiol Lett. 2004;241(2):171–7.PubMedCrossRef Fischer CR, Yoichi M, Unno H, Tanji Y. The coexistence of E. Coli serotype O157: H7 and its specific bacteriophage in continuous culture. FEMS Microbiol Lett. 2004;241(2):171–7.PubMedCrossRef
45.
go back to reference Hagens S, Loessner MJ. Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. Curr Pharm Biotechnol. 2010;11(1):58–68.PubMedCrossRef Hagens S, Loessner MJ. Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations. Curr Pharm Biotechnol. 2010;11(1):58–68.PubMedCrossRef
46.
go back to reference Haaber J, Leisner JJ, Cohn MT, Catalan-Moreno A, Nielsen JB, Westh H, et al. Bacterial viruses enable their host to acquire antibiotic resistance genes from neighboring cells. Nat Commun. 2016;7(1):13333.ADSPubMedPubMedCentralCrossRef Haaber J, Leisner JJ, Cohn MT, Catalan-Moreno A, Nielsen JB, Westh H, et al. Bacterial viruses enable their host to acquire antibiotic resistance genes from neighboring cells. Nat Commun. 2016;7(1):13333.ADSPubMedPubMedCentralCrossRef
47.
go back to reference Lee Y-D, Park J-H. Characterization and application of phages isolated from sewage for reduction of E. Coli O157: H7 in biofilm. LWT-Food Sci Technol. 2015;60(1):571–7.CrossRef Lee Y-D, Park J-H. Characterization and application of phages isolated from sewage for reduction of E. Coli O157: H7 in biofilm. LWT-Food Sci Technol. 2015;60(1):571–7.CrossRef
48.
go back to reference Ma Y, Li E, Qi Z, Li H, Wei X, Lin W, Zhao X. Isolation and molecular characterization of Achromobacter phage phiAxp-3, an N4-like bacteriophage. Sci Rep. 2016;6(1):1–12. Ma Y, Li E, Qi Z, Li H, Wei X, Lin W, Zhao X. Isolation and molecular characterization of Achromobacter phage phiAxp-3, an N4-like bacteriophage. Sci Rep. 2016;6(1):1–12.
49.
go back to reference Ackermann H-W. Frequency of morphological phage descriptions in the year 2000. Arch Virol. 2011;146(5):843–57.CrossRef Ackermann H-W. Frequency of morphological phage descriptions in the year 2000. Arch Virol. 2011;146(5):843–57.CrossRef
50.
go back to reference Jończyk E, Kłak M, Międzybrodzki R, Górski A. The influence of external factors on bacteriophages. Folia Microbiol. 2011;56(3):191–200.CrossRef Jończyk E, Kłak M, Międzybrodzki R, Górski A. The influence of external factors on bacteriophages. Folia Microbiol. 2011;56(3):191–200.CrossRef
51.
go back to reference Abdelsattar A, Dawoud A, Makky S, Nofal R, Aziz RK, El-Shibiny A. Bacteriophages: from isolation to application. Curr Pharm Biotechnol. 2022;23(3):337–60.PubMedCrossRef Abdelsattar A, Dawoud A, Makky S, Nofal R, Aziz RK, El-Shibiny A. Bacteriophages: from isolation to application. Curr Pharm Biotechnol. 2022;23(3):337–60.PubMedCrossRef
52.
go back to reference Born Y, Knecht LE, Eigenmann M, Bolliger M, Klumpp J, Fieseler L. A major-capsid-protein-based multiplex PCR assay for rapid identification of selected virulent bacteriophage types. Arch Virol. 2019;164:819–30.PubMedPubMedCentralCrossRef Born Y, Knecht LE, Eigenmann M, Bolliger M, Klumpp J, Fieseler L. A major-capsid-protein-based multiplex PCR assay for rapid identification of selected virulent bacteriophage types. Arch Virol. 2019;164:819–30.PubMedPubMedCentralCrossRef
53.
go back to reference Barylski J, Enault F, Dutilh BE, Schuller MB, Edwards RA, Gillis A, Adriaenssens EM. Analysis of spounaviruses as a case study for the overdue reclassification of tailed phages. Syst Biol. 2020;69(1):110–23.PubMedCrossRef Barylski J, Enault F, Dutilh BE, Schuller MB, Edwards RA, Gillis A, Adriaenssens EM. Analysis of spounaviruses as a case study for the overdue reclassification of tailed phages. Syst Biol. 2020;69(1):110–23.PubMedCrossRef
54.
go back to reference Alanazi F, Nour I, Hanif A, Al-Ashkar I, Aljowaie RM, Eifan S. Novel findings in context of molecular diversity and abundance of bacteriophages in wastewater environments of Riyadh, Saudi Arabia. Plos one. 2022;17(8):e0273343.PubMedPubMedCentralCrossRef Alanazi F, Nour I, Hanif A, Al-Ashkar I, Aljowaie RM, Eifan S. Novel findings in context of molecular diversity and abundance of bacteriophages in wastewater environments of Riyadh, Saudi Arabia. Plos one. 2022;17(8):e0273343.PubMedPubMedCentralCrossRef
55.
go back to reference Jurczak-Kurek A, Gąsior T, Nejman-Faleńczyk B, Bloch S, Dydecka A, Topka G, Węgrzyn A. Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage. Sci Rep. 2016;6(1):1–17.CrossRef Jurczak-Kurek A, Gąsior T, Nejman-Faleńczyk B, Bloch S, Dydecka A, Topka G, Węgrzyn A. Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage. Sci Rep. 2016;6(1):1–17.CrossRef
56.
go back to reference Potapov SA, Tikhonova IV, Krasnopeev AY, Kabilov MR, Tupikin AE, Chebunina NS, et al. Metagenomic analysis of virioplankton from the pelagic zone of Lake Baikal. Viruses. 2019;11(11):991.PubMedPubMedCentralCrossRef Potapov SA, Tikhonova IV, Krasnopeev AY, Kabilov MR, Tupikin AE, Chebunina NS, et al. Metagenomic analysis of virioplankton from the pelagic zone of Lake Baikal. Viruses. 2019;11(11):991.PubMedPubMedCentralCrossRef
Metadata
Title
Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential
Authors
Tamirat Salile Sada
Tesfaye Sisay Tessema
Publication date
01-12-2024

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.